1. Home
  2. WST vs STE Comparison

WST vs STE Comparison

Compare WST & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • STE
  • Stock Information
  • Founded
  • WST 1923
  • STE 1985
  • Country
  • WST United States
  • STE United States
  • Employees
  • WST N/A
  • STE 17787
  • Industry
  • WST Medical/Dental Instruments
  • STE Industrial Specialties
  • Sector
  • WST Health Care
  • STE Health Care
  • Exchange
  • WST Nasdaq
  • STE Nasdaq
  • Market Cap
  • WST 15.6B
  • STE 23.0B
  • IPO Year
  • WST N/A
  • STE 1992
  • Fundamental
  • Price
  • WST $227.12
  • STE $227.95
  • Analyst Decision
  • WST Buy
  • STE Buy
  • Analyst Count
  • WST 7
  • STE 9
  • Target Price
  • WST $331.67
  • STE $261.00
  • AVG Volume (30 Days)
  • WST 627.1K
  • STE 525.5K
  • Earning Date
  • WST 07-24-2025
  • STE 08-05-2025
  • Dividend Yield
  • WST 0.37%
  • STE 0.99%
  • EPS Growth
  • WST N/A
  • STE 63.01
  • EPS
  • WST 6.37
  • STE 6.21
  • Revenue
  • WST $2,895,800,000.00
  • STE $5,459,515,000.00
  • Revenue This Year
  • WST $3.38
  • STE $7.61
  • Revenue Next Year
  • WST $5.85
  • STE $6.04
  • P/E Ratio
  • WST $35.64
  • STE $37.02
  • Revenue Growth
  • WST N/A
  • STE 6.24
  • 52 Week Low
  • WST $187.43
  • STE $200.98
  • 52 Week High
  • WST $352.33
  • STE $252.79
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.84
  • STE 31.70
  • Support Level
  • WST $219.60
  • STE $229.63
  • Resistance Level
  • WST $233.84
  • STE $233.36
  • Average True Range (ATR)
  • WST 5.29
  • STE 3.86
  • MACD
  • WST 0.60
  • STE -1.33
  • Stochastic Oscillator
  • WST 66.82
  • STE 11.64

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Share on Social Networks: